Published in Prostaglandins Leukot Essent Fatty Acids on September 26, 2002
Genome sequence of Bifidobacterium breve DPC 6330, a strain isolated from the human intestine. J Bacteriol (2011) 0.77
Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb (1996) 2.00
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol (2000) 1.69
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol (2011) 1.62
Surgical management of the septic complications of diverticular disease. Ann R Coll Surg Engl (1995) 1.44
Peri-operative acute phase response and cytokine releasein women with breast cancer: modulation bypolyadenylic-polyuridylic acid. Eur J Surg Oncol (1999) 1.41
Natural killer cells and cancer. Cancer (1996) 1.33
Cognitive performance and mood after a weekend on call in a surgical unit. Br J Surg (1997) 1.30
The accuracy of "one-stop" diagnosis for 1,110 patients presenting to a symptomatic breast clinic. J R Coll Surg Edinb (1999) 1.11
Breast cancer in women aged 35 and under: prognosis and survival. J R Coll Surg Edinb (2002) 1.09
Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin Sci (Lond) (1993) 1.08
Measurement of albumin synthesis in humans: a new approach employing stable isotopes. Am J Physiol (1990) 1.05
Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Br J Cancer (1999) 1.02
Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin Cancer Res (2000) 1.01
Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr (2005) 1.00
Interleukin 2 therapy in cancer: identification of responders. Br J Cancer (1992) 1.00
Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett (2002) 1.00
The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat (2010) 1.00
Carcinoid tumour of the gall bladder: two case reports and a review of published works. Gut (1993) 0.98
Haemangiopericytoma of the greater omentum. Eur J Surg Oncol (1995) 0.97
Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. Am J Surg (1998) 0.97
Correlation of serum cytokine and acute phase reactant levels with alterations in weight and serum albumin in patients receiving immunotherapy with recombinant IL-2. Clin Exp Immunol (1994) 0.92
Interleukin 2 receptor expression and interleukin 2 localisation in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumour cell proliferation. Int J Cancer (1995) 0.91
Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer. Eur J Cancer (1999) 0.91
Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. Ann Surg (1998) 0.91
Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer. Br J Cancer (2012) 0.91
Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration. Ann Oncol (2006) 0.90
Minimal modulation of lymphocyte and natural killer cell subsets following minimal access surgery. Am J Surg (1999) 0.90
What is achieved by mammographic surveillance after breast conservation treatment for breast cancer? Am J Surg (2001) 0.90
Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest (2000) 0.89
Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Lond) (1992) 0.89
Femoral hernia: mortality and morbidity following elective and emergency surgery. J R Coll Surg Edinb (1991) 0.89
Distal procto-colitis, natural cytotoxicity, and essential fatty acids. Am J Gastroenterol (1998) 0.87
Measurement of protein synthesis in human skeletal muscle: further investigation of the flooding technique. Clin Sci (Lond) (1991) 0.86
Immune suppression and isolated severe head injury: a significant clinical problem. Br J Neurosurg (2003) 0.86
Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy. Surgery (1995) 0.85
Tumour and host tissue responses to branched-chain amino acid supplementation of patients with cancer. Clin Sci (Lond) (1994) 0.85
Interleukin-2 (IL-2) augments host cellular immune reactivity in the perioperative period in patients with malignant disease. Eur J Surg Oncol (1995) 0.84
Synthetic polyribonucleotides: current role and potential use in oncological practice. Eur J Surg Oncol (1995) 0.84
The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial. Psychooncology (1997) 0.84
Reversal of Hartmann's colostomy. J R Coll Surg Edinb (1994) 0.83
Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology (1997) 0.83
Moving inwards, moving outwards, moving upwards: the role of spirituality during the early stages of breast cancer. Eur J Cancer Care (Engl) (2011) 0.83
Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer. Clin Exp Immunol (1995) 0.82
Impaired expression of glutathione peroxidase-4 gene in peripheral blood mononuclear cells: a biomarker of increased breast cancer risk. Cancer Biomark (2010) 0.82
Freehand core biopsy in breast cancer: an accurate predictor of tumour grade following neoadjuvant chemotherapy? Breast (2002) 0.82
L-arginine stimulates host defenses in patients with breast cancer. Surgery (1994) 0.82
Regulation of fatty acid synthase (FAS) and apoptosis in estrogen-receptor positive and negative breast cancer cells by conjugated linoleic acids. Prostaglandins Leukot Essent Fatty Acids (2012) 0.82
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines. Prostaglandins Leukot Essent Fatty Acids (2011) 0.82
The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments. Eur J Cancer (1996) 0.82
Fatty acids and prostate cancer: current status and future challenges. J R Coll Surg Edinb (1999) 0.82
L-arginine and malignant disease: a potential therapeutic role? Eur J Surg Oncol (1994) 0.81
Nutritional pharmacology: effects of L-arginine on host defences, response to trauma and tumour growth. Clin Sci (Lond) (1994) 0.81
Apoptosis and prognosis in cancer: rationale and relevance. J R Coll Surg Edinb (2000) 0.80
Organ-specific measurements of protein turnover in man. Proc Nutr Soc (1991) 0.80
Cancer cachexia: pathophysiological mechanisms. Eur J Surg Oncol (1996) 0.80
In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses. Br J Cancer (1994) 0.80
Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study. Br J Cancer (1994) 0.79
Male breast cancer: clinico-pathological features, immunocytochemical characteristics and prognosis. Eur J Surg Oncol (1996) 0.79
Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J Clin Immunol (2000) 0.78
Effect of essential fatty acids on circulating T cell subsets in patients with colorectal cancer. Cancer Immunol Immunother (1994) 0.78
Arginine metabolism in benign and malignant disease of breast and colon: evidence for possible inhibition of tumor-infiltrating macrophages. Nutrition (1992) 0.78
Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. Clin Sci (Lond) (1994) 0.78
A novel diagnostic index for use in the breast clinic. J R Coll Surg Edinb (1996) 0.78
Renal function in rats treated with cyclosporin following unilateral nephrectomy. Br J Exp Pathol (1985) 0.78
Minimal access surgery for cholelithiasis induces an attenuated acute phase response. Am J Surg (1999) 0.78
Fatty acid regulation of protein kinase C isoforms in prostate cancer cells. Biochem Biophys Res Commun (2001) 0.78
Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma. Nucl Med Commun (1995) 0.78
Current and potential chemotherapeutic agents used for induction chemotherapy in the treatment of breast cancer. Curr Pharm Des (2000) 0.78
Psychosocial aspects of cancer in the elderly. Eur J Surg Oncol (1998) 0.77
Immunonutrition. Br J Surg (2003) 0.77
Recombinant interleukin-2 treatment in patients with metastatic colorectal cancer: effect on natural cytotoxicity. Cancer Immunol Immunother (1992) 0.77
Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation. Eur J Surg Oncol (1994) 0.77
Immunopathological changes in the skin following recombinant interleukin-2 treatment. J Pathol (1992) 0.77
Evidence for Fas counter attack in vivo from a study of colorectal cancer. Oncol Rep (2000) 0.77
The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat (2012) 0.77
Modulation of the cytokine and acute-phase response to major surgery by recombinant interleukin-2. Br J Surg (1995) 0.77
Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the rat. Biochem Pharmacol (1993) 0.76
Immunohistochemical detection of a germline BRCA1 mutation in a breast and ovarian cancer family. Breast (2000) 0.76
Expression of growth factor receptors is not a prognostic indicator in young patients with colorectal cancer. J R Coll Surg Edinb (1997) 0.76
Positron emission tomography: 2-deoxy-2-[18F]-fluoro-D-glucose uptake in locally advanced breast cancers. Eur J Surg Oncol (1995) 0.75
Pattern of 2-deoxy-2-[18F]-fluro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy. Nucl Med Commun (1992) 0.75
Chronic cyclosporin A (CsA) nephrotoxicity in the rat: the effect of calcium blockade with verapamil. Int J Exp Pathol (1993) 0.75
Randomized clinical trial of the effects of preoperative and postoperative oral nutritional supplements on clinical course and cost of care (Br J Surg 2004; 91: 983-990). Br J Surg (2004) 0.75
Recent advances in intensive care. More still needs to be known about immunonutrition. BMJ (2000) 0.75
Immune-enhancing diets. Crit Care Med (2000) 0.75
Comments on the role of fish-oil fatty acids in the prevention of cancer cachexia. Clin Sci (Lond) (2000) 0.75
Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. Br J Surg (1998) 0.75
The management of cancer in the elderly. J R Coll Surg Edinb (1999) 0.75
Surviving cancer: do psychosocial factors count? J Psychosom Res (1999) 0.75
Surgical management of patients with advanced cancer (I). Eur J Surg Oncol (1997) 0.75
Pattern of injuries in survivors of a helicopter crash. Injury (1987) 0.75
The management of cancer of the breast in the elderly. Eur J Surg Oncol (1998) 0.75
Alleviation of experimental cyclosporin A toxicity by substitution of fish muscle oil as drug vehicle. Immunopharmacology (1990) 0.75
Student views on the introduction of anatomy teaching packages into clinical attachments. Clin Anat (2009) 0.75
Lymphocyte protein synthesis in vivo: a measure of activation. Clin Sci (Lond) (1994) 0.75
Influence of the hepatic drug-metabolizing enzyme-inducer phenobarbitone on cyclosporine nephrotoxicity and hepatotoxicity in renal-allografted rats. Transplantation (1988) 0.75
Essential fatty acids and malignant disease. Eur J Surg Oncol (1994) 0.75
Gamma emission imaging in the management of breast disorders. Eur J Surg Oncol (1998) 0.75
A modified technique for insertion and subcutaneous tunnelling of a subclavian catheter for haemodialysis. J R Coll Surg Edinb (1985) 0.75